Cargando…
Somatic SMAD3-activating mutations cause melorheostosis by up-regulating the TGF-β/SMAD pathway
Melorheostosis is a rare sclerosing dysostosis characterized by asymmetric exuberant bone formation. Recently, we reported that somatic mosaicism for MAP2K1-activating mutations causes radiographical “dripping candle wax” melorheostosis. We now report somatic SMAD3 mutations in bone lesions of four...
Autores principales: | Kang, Heeseog, Jha, Smita, Ivovic, Aleksandra, Fratzl-Zelman, Nadja, Deng, Zuoming, Mitra, Apratim, Cabral, Wayne A., Hanson, Eric P., Lange, Eileen, Cowen, Edward W., Katz, James, Roschger, Paul, Klaushofer, Klaus, Dale, Ryan K., Siegel, Richard M., Bhattacharyya, Timothy, Marini, Joan C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Rockefeller University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7201932/ https://www.ncbi.nlm.nih.gov/pubmed/32232430 http://dx.doi.org/10.1084/jem.20191499 |
Ejemplares similares
-
Somatic activating mutations in MAP2K1 cause melorheostosis
por: Kang, Heeseog, et al.
Publicado: (2018) -
Hide and seek: Somatic SMAD3 mutations in melorheostosis
por: Velchev, Joe Davis, et al.
Publicado: (2020) -
Clinical Evaluation of Melorheostosis in the Context of a Natural History Clinical Study
por: Jha, Smita, et al.
Publicado: (2019) -
SMAD3 mutation in LDS3 causes bone fragility by impairing the TGF-β pathway and enhancing osteoclastogenesis
por: El-Gazzar, Ahmed, et al.
Publicado: (2022) -
Cross‐Sectional Imaging Useful in Melorheostosis
por: Hurley‐Novatny, Amelia, et al.
Publicado: (2021)